The number of merger and acquisition deals among healthcareIT/pharma companies declined 16 percent in 2013, but the value of deals rose, according to analysis from Berkery Noyes, an independent mid-market investment bank.
The number of merger and acquisition deals among healthcareIT/pharma companies declined 16 percent in 2013, but the value of deals rose, according to analysis from Berkery Noyes, an independent mid-market investment bank.
